Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Access to Life-Saving Medicine Act
Client: GENERAL MOTORS CORP · Firm: JENNINGS POLICY STRATEGIES
including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocate for cost containment policies
Access to Life-Saving Medicine Act
Client: GENERAL MOTORS CORP · Firm: JENNINGS POLICY STRATEGIES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via JENNINGS POLICY STRATEGIES
2007 · mid_year · MA
-Advocated for policies aimed at modifying the asset-transfer provisions of the Deficit Reduction Act of 2005 (S. 1932, H.R. 4241).
-Advocated for policies aimed at modifying the asset-transfer provisions of the Deficit Reduction Act of 2005 (S. 1932, H.R. 4241).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for cost containment policies
Access to Life-Saving Medicine Act
Client: GENERAL MOTORS CORP · Firm: JENNINGS POLICY STRATEGIES
including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for cost containment policies
To amend the Act establishing the Rivers of Steel National Heritage Area in order to include Butler County, Pennsylvania, within the boundaries of that heritage area.
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: JENNINGS POLICY STRATEGIES
-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)
To amend the Act establishing the Rivers of Steel National Heritage Area in order to include Butler County, Pennsylvania, within the boundaries of that heritage area.
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: JENNINGS POLICY STRATEGIES
-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)
To amend the Act establishing the Rivers of Steel National Heritage Area in order to include Butler County, Pennsylvania, within the boundaries of that heritage area.
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: JENNINGS POLICY STRATEGIES
-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)
Access to Life-Saving Medicine Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: JENNINGS POLICY STRATEGIES
-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)
Access to Life-Saving Medicine Act
Client: GENERAL MOTORS CORP · Firm: JENNINGS POLICY STRATEGIES
including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocate for cost containment policies
Access to Life-Saving Medicine Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: JENNINGS POLICY STRATEGIES
-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)
Access to Life-Saving Medicine Act
Client: GENERAL MOTORS CORP · Firm: JENNINGS POLICY STRATEGIES
including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for cost containment policies
Access to Life-Saving Medicine Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: JENNINGS POLICY STRATEGIES
-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)
Access to Life-Saving Medicine Act
Client: GENERAL MOTORS CORP · Firm: JENNINGS POLICY STRATEGIES
including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for cost containment policies
including generic access and comparative effectiveness (including H.R. 6257, S. 4016 and H.R. 6022, S. 2300) and policies that promote competition in the pharmaceutical marketplace -Advocated for value-based health care purchasing, including pay-for-performance legislation and health information technology -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for pharmaceutical cost-containment policies
including generic access and comparative effectiveness (including H.R. 6257, S. 4016 and H.R. 6022, S. 2300) and policies that promote competition in the pharmaceutical marketplace -Advocated for value-based health care purchasing, including pay-for-performance legislation and health information technology -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for pharmaceutical cost containment issues
including generic access and comparative effectiveness (including H.R. 6257, S. 4016 and H.R. 6022, S. 2300) and policies that promote competition in the pharmaceutical marketplace -Advocated for value-based health care purchasing, including pay-for-performance legislation and health information technology -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for pharmaceutical cost containment issues
Access to Life-Saving Medicine Act
Client: GENERAL MOTORS CORP · Firm: JENNINGS POLICY STRATEGIES
including generic access and comparative effectiveness (including H.R. 6257, S. 4016 and H.R. 6022, S. 2300) and policies that promote competition in the pharmaceutical marketplace -Advocated for value-based health care purchasing, including pay-for-performance legislation and health information technology -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for pharmaceutical cost-containment policies
Access to Life-Saving Medicine Act
Client: GENERAL MOTORS CORP · Firm: JENNINGS POLICY STRATEGIES
including generic access and comparative effectiveness (including H.R. 6257, S. 4016 and H.R. 6022, S. 2300) and policies that promote competition in the pharmaceutical marketplace -Advocated for value-based health care purchasing, including pay-for-performance legislation and health information technology -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for pharmaceutical cost containment issues
Access to Life-Saving Medicine Act
Client: GENERAL MOTORS CORP · Firm: JENNINGS POLICY STRATEGIES
including generic access and comparative effectiveness (including H.R. 6257, S. 4016 and H.R. 6022, S. 2300) and policies that promote competition in the pharmaceutical marketplace -Advocated for value-based health care purchasing, including pay-for-performance legislation and health information technology -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for pharmaceutical cost containment issues
2007 · mid_year · MA
-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)
-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)
-Advocated for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including H.R. 1083 and S. 623)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS CORP via JENNINGS POLICY STRATEGIES
2007 · mid_year · MA
including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocate for cost containment policies
including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for cost containment policies
including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for cost containment policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERIC PHARMACEUTICAL ASSOCIATION via JENNINGS POLICY STRATEGIES
2006 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ACADEMY OF ELDER LAW ATTORNEYS via JENNINGS POLICY STRATEGIES
2006 · year_end · YY
-Advocated for policies aimed at removing or modifying the asset-tranfer provisions contained in the Deficit Reduction Act of 2005 (S. 1932, H.R. 4241)
-Advocated for policies aimed at modifying the asset-transfer provisions of the Deficit Reduction Act of 2005 (S. 1932, H.R. 4241).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS CORP via JENNINGS POLICY STRATEGIES
2006 · year_end · YY
including generic access and comparative effectiveness (including H.R. 6257, S. 4016 and H.R. 6022, S. 2300) and policies that promote competition in the pharmaceutical marketplace -Advocated for value-based health care purchasing, including pay-for-performance legislation and health information technology -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for pharmaceutical cost-containment policies
including generic access and comparative effectiveness (including H.R. 6257, S. 4016 and H.R. 6022, S. 2300) and policies that promote competition in the pharmaceutical marketplace -Advocated for value-based health care purchasing, including pay-for-performance legislation and health information technology -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for pharmaceutical cost containment issues
including generic access and comparative effectiveness (including H.R. 6257, S. 4016 and H.R. 6022, S. 2300) and policies that promote competition in the pharmaceutical marketplace -Advocated for value-based health care purchasing, including pay-for-performance legislation and health information technology -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness -Advocated for pharmaceutical cost containment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE